Search results
Results from the WOW.Com Content Network
April 1, 2020 at 3:07 PM All Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, the Food and Drug Administration announced Wednesday.
The focus of Glaxo, its manufacturer, was to gain market share "from Zantac competitors like Tagamet." [9] Cimetidine, sold under the brand name Tagamet among others, was listed in 2020 as an alternative to Zantac. [11] The company also introduced a half-strength [12] Line Extension named Zantac 75. [13]
The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that ranitidine, the active ingredient in Zantac and ...
In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug.
The U.S. Food and Drug Administration in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits. The drug, approved over four decades ...
In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after NDMA was found in samples of the drug.
Sanofi acquired Zantac in 2017. Before that, other companies owned the drug. Peter Pitts, the former associate commissioner of the FDA, says these types of lawsuits are concerning for the industry.
Shares in GSK rose more than 2% to a 10-month high of 1,559 pence on Wednesday, briefly making it the best performer on London's blue-chip FTSE 100. ... The FDA in 2020 pulled all brand name ...